Cite
HARVARD Citation
Nonagase, Y. et al. (2016). Afatinib-refractory brain metastases from EGFR-mutant non-small-cell lung cancer successfully controlled with erlotinib. Anti-cancer drugs. 27 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nonagase, Y. et al. (2016). Afatinib-refractory brain metastases from EGFR-mutant non-small-cell lung cancer successfully controlled with erlotinib. Anti-cancer drugs. 27 (3), p. . [Online].